{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/drugpolicy.ca\/fr\/","author_name":"Affinity Bridge","author_url":"https:\/\/drugpolicy.ca\/fr\/author\/affinity-bridge\/","title":"Imaginer un approvisionnement s\u00e9curitaire - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"oQhhgRdihX\"><a href=\"https:\/\/drugpolicy.ca\/fr\/nos-travaux\/travaux-precedents\/imaginer-un-approvisionnement-securitaire\/\">Imaginer un approvisionnement s\u00e9curitaire<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/drugpolicy.ca\/fr\/nos-travaux\/travaux-precedents\/imaginer-un-approvisionnement-securitaire\/embed\/#?secret=oQhhgRdihX\" width=\"600\" height=\"338\" title=\"&#8220;Imaginer un approvisionnement s\u00e9curitaire&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"oQhhgRdihX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/drugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2023\/06\/banner-image-3-1.jpg","thumbnail_width":1200,"thumbnail_height":500,"description":"Le projet de recherche communautaire \u00ab\u202fImaginer un approvisionnement s\u00e9curitaire\u202f\u00bb propose des id\u00e9es sur la participation \u00e0 l\u2019approvisionnement s\u00e9curitaire. Entre janvier et juin 2021, nous avons interrog\u00e9 33\u202fpersonnes utilisatrices de drogues et du personnel de premi\u00e8re ligne quant \u00e0 leurs souhaits et leurs besoins en mati\u00e8re d\u2019approvisionnement s\u00e9curitaire. Celles-ci proviennent de la Colombie-Britannique, l\u2019Alberta, l\u2019Ontario et [&hellip;]"}